Comparative evaluation of 'TaqMan' RT-PCR and RT-PCR ELISA for immunological monitoring of renal transplant recipients

Transplant Immunology

Volumn 11, Issue 1, 2003, Pages 65-72

  Gibbs, Paul J ^a   Tan, Lam Chin ^a   Sadek, Sami A ^a   Howell, W Martin ^b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

'TaqMan'; Acute allograft rejection; Cytokines; Immunological monitoring; Renal transplantation; RT PCR ELISA

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN 4; PRIMER DNA;

ACUTE GRAFT REJECTION; ARTICLE; BIOPSY; CLINICAL ARTICLE; CLINICAL LABORATORY; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE PROBE; HUMAN; IMMUNE STATUS; IMMUNOLOGICAL MONITORING; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; LABORATORY TEST; MONONUCLEAR CELL; PERIPHERAL BLOOD STEM CELL; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; RECIPIENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS;

ENZYME-LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; INTERLEUKIN-10; INTERLEUKIN-4; KIDNEY TRANSPLANTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECTROPHOTOMETRY; T-LYMPHOCYTES;

EID: 0038029675     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(02)00086-2     Document Type: Article

References (31)

1. European Mycophenalate Mofetil Cooperation Study Group. Placebo-controlled study of mycophenalate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet 1995;345:1321-1325.
2. Jordan ML, Naraghi R, Shapiro R, et al. Tacrolimus rescue therapy for renal allograft rejection - Five-year experience. Transplantation 1997;63:223-228.
3. The Sirolimus European Renal Transplant Study Group, Groth CG, Bäckman L, Morles J-M, et al. Sirolimus (rapamycin)-based therapy in human renal transplantation. Transplantation 1999;67:1036-1042.
4. Kahan BD, Podbielski J, Napoli KL, Katz SM, Meier-Kriesche H-U, Van Buren CT. Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation. Transplantation 1998;66:1040-1046.
5. The CHIB 201 International Study Group, Nashan B, Moore R, Amlot P, Schmidt A-G, Abeywickrama K, Soulillou J-P. Randomised trial of basiliximab versus placebo for control of acute rejection in renal allograft recipients. Lancet 1997;350:1193-1198.
6. The U.K. Neoral Renal Study Group, Pollard SG, Lear PA, Ready AR, Moore RH, Johnson RWG. Comparison of microemulsion and conventional formulations of cyclosporine A in preventing acute rejection in de novo kidney transplant patients. Transplantation 1999;68:1325-1331.
7. Kirk AD, Bollinger RR, Finn OJ. Rapid, comprehensive analysis of human cytokine mRNA and its application to the study of acute renal allograft rejection. Hum Immunol 1995;43:113-128.
8. Paul WE. Pleiotrophy and redundancy: T cell-derived lymphokines in the immune response. Cell 1989;57:521-524.
9. Balkwill FR, Burke F. The cytokine network. Immunol Today 1989;10:299-304.
10. Arai KI, Lee F, Miyajima A, Miyatake S, Arai N, Yokota T. Cytokines: Coordinators of immune and inflammatory responses. Annu Rev Biochem 1990;59:783-836.
11. Krams SM, Falco DA, Villanueva JC, et al. Cytokine and T cell receptor gene expression at the site of allograft. Transplantation 1992;53:151-156.
12. Joseph JV, Guy SP, Brenchley PE, et al. Th1 and Th2 cytokine gene expression in human renal transplants. Transplant Proc 1995;27:915-916.
13. Loong CC, Chen A, Lui WY, King KL, Lin CY. Expression of cytokines, growth factors and adhesion molecules in rejecting human renal allograft. Transplant Proc 1996;28:1445-1446.
14. Pavlakis M, Strelau J, Lipman M, Shapiro M, Maslinski M, Strom TB. Intragraft IL-15 transcripts are increased in human renal allograft rejection. Transplantation 1996;62:543-545.
15. Gorzynski RM, Adams RB, Levy GA, Chung SW. Correlation of peripheral blood lymphocyte and intragraft cytokine mRNA expression with rejection in orthotopic liver transplantation. Surgery 1996;120:496-502.
16. Strehlau J, Pavlakis M, Lipman M, et al. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc Natl Acad Sci USA 1997;94:695-700.
17. Nickerson P, Steiger J, Zheng XX, et al. Manipulation of cytokine, networks in transplantation. Transplantation 1997;63:489-494.
18. Van Gelder T, Baan CC, Balk AHMM et al. Blockade of the IL-2/IL-2 receptor pathway with a monoclonal anti Interleukin-2 receptor antibody (BT563) does not prevent the development of acute heart allograft rejection in man. Transplantation 1998;65:405-410.
19. Baan CC, Weimar W. Intragraft cytokine gene expression: Implications for clinical transplantation. Transpl Int 1998;11:169-180.
20. Lipman ML, Shen Y, Jeffery JR, et al. Immune-activation gene expression in clinically stable renal allograft biopsies: Molecular evidence for subclinical rejection. Transplantation 1998;66:1673-1681.
21. Maury CPJ, Teppo A-M. Raised serum levels of cachectin/tumor necrosis factor α in renal allograft rejection. J Exp Med 1987;166:1132-1137.
22. Noronha IL, Daniel V, Rambausek M, Waldherr R, Opelz G. Soluble Interleukin-2 receptor (sIL-2R) and tumour necrosis factor plasma levels in renal allograft recipients. Transplant Proc 1990;22:1859-1860.
23. McLaughlin PJ, Aikawa AA, Davies HM, Bakran A, Sells RA, Johnson PM. Tumour necrosis factor in renal transplantation. Transplant Proc 1991;23:1289-1290.
24. Tice DG, Heintz S, Scruggs B, Hubbell C, Szmalc FS. Immune monitoring: Does the reality fulfill the promise? Transplant Proc 1993;25:2654.
25. Daniel V, Pasker S, Wiesel M, et al. Cytokine monitoring of infection and rejection in renal transplant recipients. Transplant Proc 1995;27:884-886.
26. Kutukculer N, Clark K, Rigg KM, et al. The value of posttransplant monitoring of interleukin (IL)-2, IL-3, IL-4, IL-6, IL-8 and soluble CD23 in the plasma of renal allograft recipients. Transplantation 1995;59:333-340.
27. Kimball PM, Radovancevíc B, Isom T, Spickard A, Frazier OH. The paradox of cytokine monitoring - Predictor of immunologic activity as well as immunologic silence following cardiac transplantation. Transplantation 1996;61:909-915.
28. Iacono A, Dauber J, Keenan R, et al. Interleukin 6 and interferon-γ gene expression in lung transplant recipients with refractory acute cellular rejection. Implications for monitoring and inhibition by treatment with aerosolized cyclosporine. Transplantation 1997;64:263-269.
29. Tan L, Howell WM, Smith JL, Sadek SA. Sequential monitoring of peripheral T-lymphocyte cytokine gene expression in the early post renal allograft period. Transplantation 2001;71:751-759.
30. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996;6:986-994.
31. Härtel C, Bein G, Kirchner H, Klüher H. A human whole blood assay for analysis of T-cell function by quantification of cytokine mRNA. Scand J Immunol 1999;49:649-654.